|
Thrombosis risk factors
Citations 31-40 of 56 total displayed.
|
Past content
(since Oct 2000):
|
- Thrombosis
Factors Contributing to Individual Propensity for Arterial Thrombosis
- Krzysztof Karnicki, Whyte G. Owen, Randall S. Miller, and Robert D. McBane, II
Arterioscler Thromb Vasc Biol 2002;22:1495-1499; published online before print as doi:10.1161/01.ATV.0000029968.34056.94
[Abstract]
[Full text]
- Thrombosis
Analysis of Coagulation Cascade and Endothelial Cell Activation During Inhibition of Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Pathway in Cancer Patients
- B.C. Kuenen, M. Levi, J.C.M. Meijers, A.K. Kakkar, V.W.M. van Hinsbergh, P.J. Kostense, H.M. Pinedo, and K. Hoekman
Arterioscler Thromb Vasc Biol 2002;22:1500-1505; published online before print as doi:10.1161/01.ATV.0000030186.66672.36
[Abstract]
[Full text]
- Thrombosis
Homocysteine Binds to Human Plasma Fibronectin and Inhibits Its Interaction With Fibrin
- Alana K. Majors, Shantanu Sengupta, Belinda Willard, Michael T. Kinter, Reed E. Pyeritz, and Donald W. Jacobsen
Arterioscler Thromb Vasc Biol 2002;22:1354-1359; published online before print as doi:10.1161/01.ATV.0000023899.93940.7C
[Abstract]
[Full text]
- Articles
Factors Contributing to Individual Propensity for Arterial Thrombosis
- Krzysztof Karnicki, Whyte G. Owen, Randall S. Miller, and Robert D. McBane, II
Arterioscler Thromb Vasc Biol published July 18, 2002, doi:10.1161/01.ATV.0000029968.34056.94
[Abstract]
- Thrombosis
Lp(a) Particles Mold Fibrin-Binding Properties of Apo(a) in Size-Dependent Manner: A Study With Different-Length Recombinant Apo(a), Native Lp(a), and Monoclonal Antibody
- Chantal Kang, Miguel Dominguez, Stéphane Loyau, Toshiyuki Miyata, Vincent Durlach, and Edouard Anglés-Cano
Arterioscler Thromb Vasc Biol 2002;22:1232-1238; published online before print as doi:10.1161/01.ATV.0000021144.87870.C8
[Abstract]
[Full text]
- Thrombosis
Factor V Leiden, Hormone Replacement Therapy, and Risk of Venous Thromboembolic Events in Women With Coronary Disease
- David M. Herrington, Eric Vittinghoff, Timothy D. Howard, David A. Major, John Owen, David M. Reboussin, Donald Bowden, Vera Bittner, Joel A. Simon, Deborah Grady, and Stephen B. Hulley
Arterioscler Thromb Vasc Biol 2002;22:1012-1017; published online before print as doi:10.1161/01.ATV.0000018301.91721.94
[Abstract]
[Full text]
- Thrombosis
Elevated Fibrinogen and Homocysteine Levels Enhance the Risk of Mortality in Patients From a High-Risk Preventive Cardiology Clinic
- Monica Acevedo, Gregory L. Pearce, Kandice Kottke-Marchant, and Dennis L. Sprecher
Arterioscler Thromb Vasc Biol 2002;22:1042-1045; published online before print as doi:10.1161/01.ATV.0000020007.25154.62
[Abstract]
[Full text]
- Articles
Lp(a) Particles Mold Fibrin-Binding Properties of
Apo(a) in Size-Dependent Manner. A Study With Different-Length Recombinant
Apo(a), Native Lp(a), and Monoclonal Antibody
- Chantal Kang, Miguel Dominguez, Stéphane Loyau, Toshiyuki Miyata, Vincent Durlach, and Edouard Anglés-Cano
Arterioscler Thromb Vasc Biol published May 9, 2002, doi:10.1161/01.ATV.0000021144.87870.C8
[Abstract]
- Articles
Elevated Fibrinogen and Homocysteine Levels
Enhance the Risk of Mortality in Patients From a High-Risk Preventive
Cardiology Clinic
- Monica Acevedo, Gregory L. Pearce, Kandice Kottke-Marchant, and Dennis L. Sprecher
Arterioscler Thromb Vasc Biol published April 25, 2002, doi:10.1161/01.ATV.0000020007.25154.62
[Abstract]
- Articles
Factor V Leiden, Hormone Replacement Therapy, and
Risk of Venous Thromboembolic Events in Women With Coronary
Disease
- David M. Herrington, Eric Vittinghoff, Timothy D. Howard, David A. Major, John Owen, David M. Reboussin, Donald Bowden, Vera Bittner, Joel A. Simon, Deborah Grady, and Stephen B. Hulley
Arterioscler Thromb Vasc Biol published April 11, 2002, doi:10.1161/01.ATV.0000018301.91721.94
[Abstract]
|
|
